# Use or Non-use of Epoetin Beta in Patients Infected by Chronic Hepatitis C

> **NCT00262379** · PHASE3 · COMPLETED · sponsor: **University Hospital, Angers** · enrollment: 229 (actual)

## Conditions studied

- Chronic Hepatitis C

## Interventions

- **DRUG:** epoetin beta (NeoRecormon®)

## Key facts

- **NCT ID:** NCT00262379
- **Lead sponsor:** University Hospital, Angers
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-12
- **Primary completion:** 2009-06
- **Final completion:** 2009-06
- **Target enrollment:** 229 (ACTUAL)
- **Last updated:** 2014-12-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00262379

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00262379, "Use or Non-use of Epoetin Beta in Patients Infected by Chronic Hepatitis C". Retrieved via AI Analytics 2026-07-28 from https://api.ai-analytics.org/clinical/NCT00262379. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*